{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:13:59Z","timestamp":1793513639083,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.obpill.2026.100281","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:40:56Z","timestamp":1780123256000},"page":"100281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effects of lifestyle and glucagon-like Peptide-1 receptor agonist-based therapies on waist circumference: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4141-5187","authenticated-orcid":false,"given":"S.","family":"Ghosal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ghosal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.obpill.2026.100281_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.obpill.2026.100281_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.922931","article-title":"Abdominal visceral adipose tissue and all-cause mortality: a systematic review","volume":"13","author":"Saad","year":"2022","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.obpill.2026.100281_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/er.2017-00253","article-title":"The science of obesity management: an endocrine society scientific statement","volume":"39","author":"Bray","year":"2018","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.462","article-title":"Glucagon-like peptide agonists: a prospective review","volume":"7","author":"Mariam","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2026.100281_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2024.04.041","article-title":"Long-term efficacy and safety of once-weekly semaglutide for weight loss in patients without diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"222","author":"Moiz","year":"2024","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.obpill.2026.100281_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"SURMOUNT-1 investigators. Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.obpill.2026.100281_bib8","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"SELECT trial investigators. Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7570\/jomes20065","article-title":"Optimal diet strategies for weight loss and weight loss maintenance","volume":"30","author":"Kim","year":"2021","journal-title":"J Obes Metab Syndr"},{"issue":"5","key":"10.1016\/j.obpill.2026.100281_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.amjcard.2019.12.006","article-title":"Meta-analysis of the relation of body mass index to cardiovascular outcomes in patients receiving intensive low-density lipoprotein cholesterol lowering therapy","volume":"125","author":"Khan","year":"2020","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.obpill.2026.100281_bib11","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/nu16152443","article-title":"Impact of a mediterranean-inspired diet on cardiovascular disease risk factors: a randomized clinical trial","volume":"16","author":"Barbosa","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29495-3","article-title":"Weight loss and metabolic health effects from energy-restricted mediterranean and Central-European diets in postmenopausal women: a randomized controlled trial","volume":"8","author":"Bajerska","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.obpill.2026.100281_bib13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.2337\/dc22-0338","article-title":"Lifestyle intervention strategy to treat diabetes in older adults: a randomized controlled trial","volume":"45","author":"Celli","year":"2022","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.obpill.2026.100281_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.crad.2020.02.014","article-title":"MRI estimated changes in visceral adipose tissue and liver fat fraction in patients with obesity during a very low-calorie-ketogenic diet compared to a standard low-calorie diet","volume":"75","author":"Cunha","year":"2020","journal-title":"Clin Radiol"},{"key":"10.1016\/j.obpill.2026.100281_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/CIA.S388026","article-title":"Effects of high-intensity resistance training on visceral adipose tissue and abdominal aortic calcifications in older men with osteosarcopenia - results from the FrOST study","volume":"18","author":"Knauer","year":"2023","journal-title":"Clin Interv Aging"},{"issue":"6","key":"10.1016\/j.obpill.2026.100281_bib16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/liv.15264","article-title":"Impact of a mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: the MEDINA randomised controlled trial","volume":"42","author":"George","year":"2022","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.obpill.2026.100281_bib17","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3390\/nu12102917","article-title":"Effects of a low-fat vegan diet on gut microbiota in overweight individuals and relationships with body weight, body composition, and insulin sensitivity. A randomized clinical trial","volume":"12","author":"Kahleova","year":"2020","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.obpill.2026.100281_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37994","article-title":"An energy-reduced mediterranean diet, physical activity, and body composition: an interim subgroup analysis of the PREDIMED-plus randomized clinical trial","volume":"6","author":"Konieczna","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"24","key":"10.1016\/j.obpill.2026.100281_bib19","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.3390\/nu16244255","article-title":"Effects of a one-year intensified weight loss program on body composition parameters in patients with severe obesity and Obstructive Sleep Apnea (OSA): a randomized controlled trial","volume":"16","author":"Miralles-Llum\u00e0","year":"2024","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.obpill.2026.100281_bib20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12020-016-1050-2","article-title":"Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease","volume":"54","author":"Moreno","year":"2016","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.obpill.2026.100281_bib21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.orcp.2021.10.003","article-title":"Effectiveness to promote weight loss maintenance and healthy lifestyle habits of a group educational intervention program in adults with obesity: IGOBE program","volume":"15","author":"Porca","year":"2021","journal-title":"Obes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.obpill.2026.100281_bib22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/nu12020482","article-title":"The effect of an 8 week prescribed exercise and low-carbohydrate diet on cardiorespiratory fitness, body composition and cardiometabolic risk factors in Obese individuals: a randomised controlled trial","volume":"12","author":"Perissiou","year":"2020","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.obpill.2026.100281_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.13733","article-title":"Effect of weight loss via severe vs moderate energy restriction on lean mass and body composition among postmenopausal women with obesity: the TEMPO diet randomized clinical trial","volume":"2","author":"Seimon","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.obpill.2026.100281_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000497066","article-title":"Effects of a hypocaloric, nutritionally complete, higher protein meal plan on regional body fat and cardiometabolic biomarkers in older adults with obesity","volume":"74","author":"Serra","year":"2019","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12916-025-04072-4","article-title":"Effect of hypoglycemic agents with weight loss effect plus a high protein diet and moderate exercise on diabetes remission in adults with obesity and type 2 diabetes: a randomized controlled trial","volume":"23","author":"Zhang","year":"2025","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.obpill.2026.100281_bib26","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.metabol.2015.07.007","article-title":"A randomized trial comparing the effect of weight loss and exercise training on insulin sensitivity and glucose metabolism in coronary artery disease","volume":"64","author":"Pedersen","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.obpill.2026.100281_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5071740","article-title":"Comparable effects of high-intensity interval training and prolonged continuous exercise training on abdominal visceral fat reduction in Obese young women","volume":"2017","author":"Zhang","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.obpill.2026.100281_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.physbeh.2018.03.014","article-title":"A one-year resistance training program following weight loss has no significant impact on body composition and energy expenditure in postmenopausal women living with overweight and obesity","volume":"189","author":"Hintze","year":"2018","journal-title":"Physiol Behav"},{"issue":"2","key":"10.1016\/j.obpill.2026.100281_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13789","article-title":"Resistance and impact training during weight loss improves physical function and body composition in older adults with obesity","volume":"16","author":"Mesinovic","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.obpill.2026.100281_bib30","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/nu17111822","article-title":"Efficacy of power training on sarcopenic obesity in community-dwelling older women: a 32-Week randomized clinical trial","volume":"17","author":"Polo-Ferrero","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12889-019-6510-1","article-title":"Effect of diet with or without exercise on abdominal fat in postmenopausal women - a randomised trial","volume":"19","author":"van Gemert","year":"2019","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/gerona\/glab111","article-title":"Effect of aerobic or resistance exercise, or both, on intermuscular and visceral fat and physical and metabolic function in older adults with obesity while dieting","volume":"77","author":"Waters","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"10.1016\/j.obpill.2026.100281_bib33","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/dc17-0589","article-title":"Effects of liraglutide on weight loss, fat distribution, and \u03b2-Cell function in obese subjects with prediabetes or early type 2 diabetes","volume":"40","author":"Santilli","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00125-019-05021-6","article-title":"Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation","volume":"63","author":"Bizino","year":"2020","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.obpill.2026.100281_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2213-8587(21)00179-0","article-title":"Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial","volume":"9","author":"Neeland","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12933-019-0890-5","article-title":"A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients","volume":"18","author":"van Eyk","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.obpill.2026.100281_bib37","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1111\/dom.15113","article-title":"Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: a randomized trial in adults with obesity and prediabetes","volume":"25","author":"Silver","year":"2023","journal-title":"Diabetes Obes Metabol"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/dom.13053","article-title":"Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial","volume":"20","author":"Fr\u00f8ssing","year":"2018","journal-title":"Diabetes Obes Metabol"},{"issue":"7","key":"10.1016\/j.obpill.2026.100281_bib39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jamapsychiatry.2017.1220","article-title":"Effect of liraglutide treatment on prediabetes and overweight or obesity in Clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial","volume":"74","author":"Larsen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.obpill.2026.100281_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.951570","article-title":"Effects of liraglutide or lifestyle interventions combined with other antidiabetic drugs on abdominal fat distribution in people with obesity and type 2 diabetes mellitus evaluated by the energy spectrum ct: a prospective randomized controlled study","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.obpill.2026.100281_bib41","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ijo.2011.158","article-title":"NN8022-1807 investigators. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide","volume":"36","author":"Astrup","year":"2012","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.obpill.2026.100281_bib42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00125-019-05065-8","article-title":"Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial","volume":"63","author":"McCrimmon","year":"2020","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.obpill.2026.100281_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S2213-8587(22)00008-0","article-title":"STEP 6 investigators. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an East Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial","volume":"10","author":"Kadowaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.obpill.2026.100281_bib44","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.obpill.2026.100281_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","article-title":"Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial","volume":"10","author":"Gastaldelli","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.obpill.2026.100281_bib46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S2213-8587(25)00092-0","article-title":"Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial","volume":"13","author":"Coskun","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"13","key":"10.1016\/j.obpill.2026.100281_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310449","article-title":"Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials","volume":"24","author":"Popoviciu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.obpill.2026.100281_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/191209","article-title":"Baseline obesity status modifies effectiveness of adapted diabetes prevention program lifestyle interventions for weight management in primary care","volume":"2013","author":"Azar","year":"2013","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.obpill.2026.100281_bib49","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2337\/db11-1300","article-title":"The critical role of metabolic pathways in aging","volume":"61","author":"Barzilai","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.obpill.2026.100281_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12937-023-00909-x","article-title":"Combined versus independent effects of exercise training and intermittent fasting on body composition and cardiometabolic health in adults: a systematic review and meta-analysis","volume":"23","author":"Khalafi","year":"2024","journal-title":"Nutr J"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:32:10Z","timestamp":1787988730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S2667368126000379"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100281","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of lifestyle and glucagon-like Peptide-1 receptor agonist-based therapies on waist circumference: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100281"}}